134 related articles for article (PubMed ID: 6255652)
1. [Normalization of obstructive lung insufficiency in patients under cytostatic treatment for small cell anaplastic lung carcinoma].
Osterlind K; Dombernowsky P; Schroll M; Rose C
Ugeskr Laeger; 1980 Oct; 142(41):2688-90. PubMed ID: 6255652
[No Abstract] [Full Text] [Related]
2. [Combination chemotherapy of the superior vena cava syndrome in small cell anaplastic lung carcinoma].
Dombernowsky P; Hansen HH
Ugeskr Laeger; 1980 Oct; 142(41):2685-7. PubMed ID: 6255651
[No Abstract] [Full Text] [Related]
3. Leukemia occurring after treatment of small cell lung cancer.
Vogelzang NJ; Arthur D; Kennedy BJ
Cancer Treat Rep; 1982 Aug; 66(8):1683-4. PubMed ID: 6286123
[No Abstract] [Full Text] [Related]
4. [Cytostatic chemotherapy and radiotherapy in small cell anaplastic lung carcinoma. Results of 2 prospective studies].
Hansen HH; Dombernowsky P; Hansen M; Hirsch F; Rygård J
Ugeskr Laeger; 1980 Oct; 142(41):2681-5. PubMed ID: 6255650
[No Abstract] [Full Text] [Related]
5. [Quality of life of patients with small cell lung cancer can be improved by treatment with cytostatic agents].
Bergman B
Lakartidningen; 1992 May; 89(19):1681-5. PubMed ID: 1315895
[No Abstract] [Full Text] [Related]
6. Myasthenic syndrome and small cell cancer of the lung. Variable response to antineoplastic therapy.
Clamon GH; Evans WK; Shepherd FA; Humphrey JG
Arch Intern Med; 1984 May; 144(5):999-1000. PubMed ID: 6324711
[TBL] [Abstract][Full Text] [Related]
7. [Effects, possibilities and limits. Cytostatic therapy of small cell and non-small cell lung cancer].
Bergman B
Lakartidningen; 1997 Apr; 94(18):1702, 1707-10. PubMed ID: 9182178
[No Abstract] [Full Text] [Related]
8. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
[No Abstract] [Full Text] [Related]
9. [Small cell anaplastic carcinoma of the lung].
Ugeskr Laeger; 1975 Jun; 137(26):1449-53. PubMed ID: 167484
[No Abstract] [Full Text] [Related]
10. Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
Fuks JZ; Van Echo DA; Aisner J; Von Hoff D; Wiernik PH
Cancer Treat Rep; 1981; 65(1-2):133-4. PubMed ID: 6261947
[No Abstract] [Full Text] [Related]
11. [Small cell lung cancer revealed by extramembranous glomerulonephritis].
Grivaux M; Renault D; Gallois JC; Barbanel C; Blanchon F
Rev Mal Respir; 2001 Apr; 18(2):197-9. PubMed ID: 11424717
[TBL] [Abstract][Full Text] [Related]
12. [Interstitial pneumonia as the cause of death during treatment of small-cell lung cancer].
Szczepek B; Szymańska D; Chojak E; Pawlicka L; Rowińska-Zakrzewska E
Pneumonol Pol; 1986 Nov; 54(11):510-21. PubMed ID: 3035510
[No Abstract] [Full Text] [Related]
13. CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.
Cambareri RJ; Smith FP; Macdonald JS; Haidak DJ; Ueno WM; Hoth DH; Woolley PV; Schein PS
Cancer Treat Rep; 1981; 65(3-4):317-20. PubMed ID: 6263471
[No Abstract] [Full Text] [Related]
14. Phase II evaluation of triazinate in patients with metastatic lung cancer.
Creagan ET; Eagan RT; Fleming TR; Frytak S; Ingle JN; Kvols LK; Nichols WC
Cancer Treat Rep; 1980; 64(10-11):1057-9. PubMed ID: 6257389
[No Abstract] [Full Text] [Related]
15. [Prolonging of life with cytostatic treatment: is it worthwhile?].
Burghouts JT
Ned Tijdschr Geneeskd; 1989 Nov; 133(44):2153-5. PubMed ID: 2554157
[No Abstract] [Full Text] [Related]
16. [Recent development in the treatment of lung cancer: from the point of view of the medical oncologist].
Joss R
Schweiz Med Wochenschr; 2000 May; 130(19):684-90. PubMed ID: 10846762
[TBL] [Abstract][Full Text] [Related]
17. Topotecan for the treatment of small-cell lung cancer.
Nicum SJ; O'Brien ME
Expert Rev Anticancer Ther; 2007 Jun; 7(6):795-801. PubMed ID: 17555389
[TBL] [Abstract][Full Text] [Related]
18. [Role of carboplatin in the treatment of lung cancer].
Bréchot JM
Bull Cancer; 2000 Aug; 87 Spec No():34-9. PubMed ID: 11082721
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of bronchial carcinoma (author's transl)].
Debevec M; Klevisar M
Plucne Bolesti Tuberk; 1981; 33(4):238-44. PubMed ID: 6285404
[No Abstract] [Full Text] [Related]
20. Second line treatment (2 LT) in small cell lung cancer (SC).
Clerici M
Anticancer Res; 1994; 14(1B):337-9. PubMed ID: 8166479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
